4.7 Article

Stem Cell Technology for Neurodegenerative Diseases

Journal

ANNALS OF NEUROLOGY
Volume 70, Issue 3, Pages 353-361

Publisher

WILEY
DOI: 10.1002/ana.22487

Keywords

-

Funding

  1. A. Alfred Taubman Medical Research Institute
  2. Program for Neurology Research and Discovery
  3. NINDS [T32 NS007222-28]
  4. Juvenile Diabetes Research Foundation

Ask authors/readers for more resources

Over the past 20 years, stem cell technologies have become an increasingly attractive option to investigate and treat neurodegenerative diseases. In the current review, we discuss the process of extending basic stem cell research into translational therapies for patients suffering from neurodegenerative diseases. We begin with a discussion of the burden of these diseases on society, emphasizing the need for increased attention toward advancing stem cell therapies. We then explain the various types of stem cells utilized in neurodegenerative disease research, and outline important issues to consider in the transition of stem cell therapy from bench to bedside. Finally, we detail the current progress regarding the applications of stem cell therapies to specific neurodegenerative diseases, focusing on Parkinson disease, Huntington disease, Alzheimer disease, amyotrophic lateral sclerosis, and spinal muscular atrophy. With a greater understanding of the capacity of stem cell technologies, there is growing public hope that stem cell therapies will continue to progress into realistic and efficacious treatments for neurodegenerative diseases. ANN NEUROL 2011;70:353-361

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available